To investigate the mechanism underlying tumor control in Prf1–/–MMTV-PyMT mice treated with the HO inhibitor SnMP, we analyzed tumors 36 hours after the initiation of treatment to capture the earliest biological changes in the TME (Figure 2A). The gene discussed is PRF1; the disease is neoplasm.